8-K: Semler Scientific Reports Q3 2024 Results, Continues Bitcoin Accumulation Strategy

Semler Scientific announced its third quarter 2024 financial results, highlighted by a decrease in revenue but an increase in net income, alongside further investment in Bitcoin.

Summary

• Semler Scientific reported a revenue of $13.5 million for the third quarter of 2024, a 17% decrease compared to $16.3 million in the same period of 2023.
• The company's cost of revenues increased slightly by 4% to $1.2 million, while total operating expenses decreased by 16% to $8.4 million.
• Income from operations was $5.1 million, a 20% decrease from $6.3 million in the prior year's quarter.
• Pre-tax income was $6.4 million, which includes a $1.1 million unrealized gain from Bitcoin holdings, a 9% decrease compared to $7.0 million.
• Net income increased by 2% to $5.6 million, or $0.80 per basic share and $0.72 per diluted share.
• Semler Scientific purchased an additional 47 bitcoins for $3.0 million since August 26, 2024, bringing their total holdings to 1,058 bitcoins with a total purchase amount of $71.0 million as of November 4, 2024.
• The company sold 86,734 shares under its ATM program for net proceeds of approximately $2.5 million as of September 30, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative due to the revenue decline and decrease in operating income, offset by the increase in net income and continued Bitcoin accumulation strategy. The company's focus on Bitcoin is a high-risk strategy that could be viewed positively or negatively depending on the investor's risk tolerance.

Positives

• Net income increased by 2% to $5.6 million, or $0.80 per basic share and $0.72 per diluted share.
• Operating expenses decreased by 16% to $8.4 million.
• The company continues to accumulate Bitcoin, which they view as a key strategy for maximizing stakeholder value.
• Semler Scientific is exploring additional financing opportunities to acquire more Bitcoin.

Negatives

• Revenue decreased by 17% to $13.5 million compared to the same quarter last year.
• Income from operations decreased by 20% to $5.1 million.
• Pre-tax income decreased by 9% to $6.4 million.
• The company's two largest customers accounted for 44% and 29% of Q3 2024 revenues, indicating a high customer concentration risk.

Risks

• The company faces risks inherent with investing in Bitcoin, including its volatility.
• There is a risk of implementing a new Bitcoin treasury strategy.
• The company is subject to the risk that insurance plans and other customers may not continue to license its cardiovascular testing products.
• Changes in the reimbursement landscape for its customers, including related to the Centers for Medicare and Medicaid Services (CMS) rate announcement, pose a risk.
• There is a risk of not obtaining a new 510(k) clearance for expanded indications for QuantaFlo.

Future Outlook

Semler Scientific plans to continue purchasing Bitcoin with cash from operations and proceeds from its ATM program, and is exploring additional financing opportunities to acquire more Bitcoin. They are also seeking a new 510(k) clearance for QuantaFlo with expanded indications.

Management Comments

• We are pleased to report strong performance from our healthcare business with income from operations of $5.1 million in the third quarter, said Doug Murphy-Chutorian, MD, chief executive officer of Semler Scientific.
• We remain laser focused on acquiring and holding bitcoin, while supporting innovation and growth in our healthcare business.
• We are capitalizing on the opportunity to maximize stakeholder value by accumulating bitcoin, said Eric Semler, chairman of Semler Scientific.

Industry Context

Semler Scientific's focus on Bitcoin as a treasury asset is a unique strategy compared to most healthcare technology companies. The company's performance is also impacted by the broader healthcare reimbursement landscape and the adoption of its QuantaFlo technology.

Comparison to Industry Standards

• Semler Scientific's revenue decline of 17% contrasts with some other medical device companies that have shown growth in the same period, such as Intuitive Surgical which reported a 12% increase in revenue in their most recent quarter.
• The company's focus on Bitcoin as a treasury asset is highly unusual compared to peers like Masimo or Medtronic, which typically invest in more traditional assets.
• The company's net income increase of 2% is modest compared to some other healthcare companies that have reported double-digit growth in net income.
• The company's customer concentration, with two customers accounting for 44% and 29% of revenue, is higher than many of its peers, which typically have a more diversified customer base.

Stakeholder Impact

• Shareholders may be impacted by the company's Bitcoin investment strategy and the volatility of Bitcoin.
• Employees may be impacted by the company's focus on Bitcoin and its potential impact on the company's financial stability.
• Customers may be impacted by the company's ability to continue to innovate and provide quality products and services.
• Suppliers may be impacted by the company's financial performance and its ability to pay its bills.

Next Steps

• Semler Scientific will continue to purchase Bitcoin with cash from operations and proceeds from its ATM program.
• The company will explore additional financing opportunities to acquire more Bitcoin.
• Semler Scientific will seek a new 510(k) clearance for QuantaFlo with expanded indications.
• The company will host a conference call to discuss the results and provide a business update.

Key Dates

Keywords

Semler Scientific, Bitcoin, Financial Results, Q3 2024, Healthcare, QuantaFlo, ATM Offering, Cardiovascular, Digital Assets, Revenue, Net Income